Serum miRNA as a possible biomarker in the diagnosis of bipolar II disorder

Sheng Yu Lee, Ru Band Lu, Liang Jen Wang, Cheng Ho Chang, Ti Lu, Tzu Yun Wang, Kuo Wang Tsai

Research output: Contribution to journalArticlepeer-review

34 Citations (Scopus)


The diagnosis of Bipolar II disorder (BD-II) is currently based on the patients’ description of symptoms and clinical behavioral observations. This study explored the possibility of miRNA in peripheral blood (serum) as a specific biomarker for BD-II. We identified 6 candidate miRNAs to differentiate BD-II patients from controls using next-generation sequencing. We then examined these candidate miRNAs using real-time PCR in the first cohort (as training group) of 79 BD-II and 95 controls. A diagnostic model was built based on these candidate miRNAs and then tested on an individual testing group (BD-II: n = 20, controls: n = 20). We found that serum expression levels of miR-7-5p, miR-23b-3p, miR-142-3p, miR-221-5p, and miR-370-3p significantly increased in BD-II compared with controls in the first cohort, whereas that of miR-145-5p showed no significant difference. The diagnostic power of the identified miRNAs was further analyzed using receiver-operating characteristic (ROC). Support vector machine (SVM) measurements revealed that a combination of the significant miRNAs reached good diagnostic accuracy (AUC: 0.907). We further examined an independent testing group and the diagnostic power reached fair for BD-II (specificity = 90%, sensitivity = 85%). We constructed miRNA panels using SVM model, which may aid in the diagnosis for BD-II.

Original languageEnglish
Article number1131
JournalScientific reports
Issue number1
Publication statusPublished - 2020 Dec 1

All Science Journal Classification (ASJC) codes

  • General


Dive into the research topics of 'Serum miRNA as a possible biomarker in the diagnosis of bipolar II disorder'. Together they form a unique fingerprint.

Cite this